2023 annual financial data
Aldeyra Therapeutics 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -42,794,083 USD and net income was -37,542,510 USD.
Operating cash flow was -30,326,128 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -42,794,083 USD
- Net income
- -37,542,510 USD
- Operating cash flow
- -30,326,128 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Aldeyra Therapeutics financial years